CRIS Current Research Information System

GATTO, LIDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.208
AS - Asia 2.942
EU - Europa 1.994
AF - Africa 261
SA - Sud America 173
OC - Oceania 6
Totale 8.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.142
SG - Singapore 881
VN - Vietnam 758
CN - Cina 717
IT - Italia 591
GB - Regno Unito 297
SE - Svezia 218
DE - Germania 186
HK - Hong Kong 184
FR - Francia 123
BR - Brasile 114
RU - Federazione Russa 103
IN - India 98
CH - Svizzera 97
IE - Irlanda 87
NL - Olanda 87
CI - Costa d'Avorio 81
KR - Corea 81
TG - Togo 54
SC - Seychelles 50
FI - Finlandia 49
ZA - Sudafrica 44
JP - Giappone 40
CA - Canada 39
ID - Indonesia 32
AR - Argentina 29
BD - Bangladesh 24
PH - Filippine 24
PL - Polonia 23
BG - Bulgaria 22
EE - Estonia 22
TW - Taiwan 20
AT - Austria 17
UA - Ucraina 17
MX - Messico 15
BE - Belgio 14
JO - Giordania 14
TH - Thailandia 13
PK - Pakistan 12
NG - Nigeria 10
TR - Turchia 8
CL - Cile 7
ES - Italia 7
AU - Australia 6
EC - Ecuador 6
EG - Egitto 6
SK - Slovacchia (Repubblica Slovacca) 6
UZ - Uzbekistan 6
HR - Croazia 5
LT - Lituania 5
MY - Malesia 5
SA - Arabia Saudita 5
CO - Colombia 4
NI - Nicaragua 4
RO - Romania 4
VE - Venezuela 4
DZ - Algeria 3
IQ - Iraq 3
IR - Iran 3
LB - Libano 3
PE - Perù 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
NO - Norvegia 2
PR - Porto Rico 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
ZW - Zimbabwe 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GN - Guinea 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
SV - El Salvador 1
Totale 8.584
Salva come PNG Salva come JPEG
Città #
Singapore 641
Ashburn 395
Chandler 262
Southend 250
Fairfield 244
Hanoi 195
Ho Chi Minh City 189
Hong Kong 172
San Jose 153
Hefei 142
Santa Clara 139
Bologna 114
Houston 103
Beijing 100
Woodbridge 98
Seattle 95
Bern 92
Wilmington 92
Princeton 88
Dublin 87
Ann Arbor 84
Abidjan 81
Cambridge 68
Boardman 67
Seoul 67
Redmond 60
Council Bluffs 59
New York 55
Lauterbourg 54
Lomé 54
Los Angeles 48
Dallas 46
Helsinki 41
Milan 41
Da Nang 38
Rome 38
Tokyo 30
Berlin 28
Frankfurt am Main 27
Haiphong 26
Redondo Beach 25
Westminster 24
Sofia 22
Buffalo 21
Jakarta 21
São Paulo 21
Montreal 20
Nanjing 20
Guangzhou 19
Turin 19
Warsaw 18
Johannesburg 17
San Diego 16
Chicago 15
London 15
Padova 15
Ravenna 15
Amman 14
Changsha 14
Jinan 14
Kuban 13
Zhengzhou 13
Bengaluru 12
Brussels 12
Falls Church 12
Shenyang 12
Tianjin 12
Biên Hòa 11
Bến Tre 11
Florence 11
Forlì 11
Hyderabad 11
Naples 11
San Francisco 11
Hangzhou 10
Shanghai 10
Torino 10
Yubileyny 10
Abeokuta 9
Denver 9
Munich 9
Phoenix 9
Toronto 9
Vienna 9
Amsterdam 8
Orem 8
Boston 7
Bremen 7
Changzhou 7
Falkenstein 7
Hebei 7
Hải Dương 7
Manila 7
Norwalk 7
Olalla 7
Saint Petersburg 7
Shenzhen 7
Verona 7
Boydton 6
Brooklyn 6
Totale 5.397
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 461
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 281
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 275
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 246
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 237
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 234
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 222
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 221
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 221
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 205
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 196
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 192
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 175
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 173
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 171
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 168
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 166
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 166
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis. 166
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 165
Glioblastoma: Emerging treatments and novel trial designs 161
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 160
Radiotherapy in the management of gist: state of the art and new potential scenarios 158
The clinical and prognostic role of ALK in glioblastoma 155
SDHA and SDHB mutations in KIT/PDGFRA WT gastrointestinal stromal tumors 151
The human microbiota and prostate cancer: Friend or foe? 146
Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report 144
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? 143
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study 143
Adult Medulloblastoma: Updates on Current Management and Future Perspectives 141
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem 137
Optical coherence tomography assessment of macrophages accumulation in non-ST-segment elevation acute coronary syndromes. 136
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 135
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review 133
Idh1 non-canonical mutations and survival in patients with glioma 128
IDH1105GGT single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomas 126
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective study 126
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer? 126
Discovering the molecular landscape of meningioma: The struggle to find new therapeutic targets 125
Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas 118
Machine learning in neuro-oncology: toward novel development fields 114
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer 109
Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers 108
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report 108
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment 107
Optimizing renal function and outcome of patients with cT2 renal cell carcinoma 105
How to predict progression-free survival in patients with grade 2 IDH-mutated diffuse gliomas after surgery: a long-term follow-up analysis 104
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 99
null 98
Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 98
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light 98
TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype 91
Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives. 88
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: An unassessed issue 84
Targeting Mitochondria in Glioma: New Hopes for a Cure 72
Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients? 46
Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back? 38
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue 32
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 32
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes 28
Totale 8.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.749
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022855 57 31 19 44 67 37 15 97 46 75 245 122
2022/20231.193 104 153 52 131 77 112 39 73 216 43 59 134
2023/2024387 44 78 26 34 19 76 12 30 7 22 17 22
2024/20251.429 101 184 128 83 199 79 88 84 22 116 97 248
2025/20263.473 289 329 261 268 333 192 476 137 726 244 112 106
Totale 8.792